elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
s10549-010-1002-0
s10549-010-1002-0
https://scigraph.springernature.com/pub.10.1007/s10549-010-1002-0
Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer.
P2888
Q33390438-F47DA604-1090-46B2-8EB4-DD5E0853FB07
P2888
s10549-010-1002-0
https://scigraph.springernature.com/pub.10.1007/s10549-010-1002-0